(Q37976140)

26 August 2017

title

Reviewing the somatic genetics of melanoma: from current to future analytical approaches (English)

1 reference

26 August 2017

Ken Dutton-Regester

1

1 reference

26 August 2017

Nicholas K Hayward

series ordinal

2

1 reference

26 August 2017

publication date

13 February 2012

1 reference

Pigment Cell & Melanoma Research

26 August 2017

published in

1 reference

26 August 2017

volume

25

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

144-154

1 reference

An integrated approach to uncover drivers of cancer.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Molecular profiling of the "plexinome" in melanoma and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Integrative analysis of the melanoma transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Functional viability profiles of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Frequent MAGE mutations in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Somatic activation of KIT in distinct subtypes of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

A novel AKT3 mutation in melanoma tumours and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Identification of fusion genes in breast cancer by paired-end RNA-sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

MEK1 mutations confer resistance to MEK and B-RAF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Functional parsing of driver mutations in the colorectal cancer genome reveals numerous suppressors of anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Mutagen-specific mutation signature determines global microRNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

DNA methylation regulates MicroRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

The genetics of uveal melanoma: an emerging framework for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Inheritance of a Cancer-AssociatedMLH1Germ-Line Epimutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Dominantly Inherited Constitutional Epigenetic Silencing of MLH1 in a Cancer-Affected Family Is Linked to a Single Nucleotide Variant within the 5′UTR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Protein interaction network topology uncovers melanogenesis regulatory network components within functional genomics datasets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

International network of cancer genome projects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

The histone variant macroH2A suppresses melanoma progression through regulation of CDK8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Genome-wide screen of promoter methylation identifies novel markers in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Modeling genomic diversity and tumor dependency in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Increasing burden of melanoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Profiling critical cancer gene mutations in clinical tumor samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Transcriptome sequencing to detect gene fusions in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

MEK1 mutations, but not ERK2 mutations, occur in melanomas and colon carcinomas, but none in thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

A comprehensive catalogue of somatic mutations from a human cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Personalized oncology through integrative high-throughput sequencing: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Proinvasion metastasis drivers in early-stage melanoma are oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Cutaneous melanoma susceptibility and progression genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Characterization of the Melanoma miRNAome by Deep Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

RNAi screen for rapid therapeutic target identification in leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

A melanoma molecular disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Delving into somatic variation in sporadic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

Exome sequencing identifies GRIN2A as frequently mutated in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

microRNAs exhibit high frequency genomic alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

High-throughput oncogene mutation profiling in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.00975.X

10.1111/J.1755-148X.2012.00975.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference